悦心健康
(002162)
| 流通市值：37.93亿 | | | 总市值：37.98亿 |
| 流通股本：9.18亿 | | | 总股本：9.20亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 508,629,451.72 | 210,618,689.84 | 1,061,871,436.31 | 771,308,298.16 |
| 营业总成本 | 496,476,436.77 | 210,377,083.24 | 1,054,181,699.28 | 772,782,653.64 |
| 其他经营收益 | | | | |
| 营业利润 | 9,846,916.03 | -2,499,601.49 | 7,813,512.96 | 3,735,902.32 |
| 利润总额 | 8,468,855.2 | -2,522,691.56 | 9,112,145.8 | 4,946,938.63 |
| 净利润 | 7,182,673.56 | -3,121,431.66 | 5,973,915.56 | 1,936,682.35 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | 0 | - | - |
| 综合收益总额 | 7,182,673.56 | -3,121,431.66 | 5,973,915.56 | 1,936,682.35 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 674,305,241.09 | 565,230,439.03 | 580,022,190.2 | 670,307,389.01 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,297,693,516.77 | 1,355,165,630.62 | 1,359,980,737.24 | 1,335,492,087.25 |
| 资产总计 | 1,971,998,757.86 | 1,920,396,069.65 | 1,940,002,927.44 | 2,005,799,476.26 |
| 流动负债: | | | | |
| 流动负债合计 | 670,472,894.87 | 625,863,086.02 | 642,783,259.62 | 723,303,296.17 |
| 非流动负债: | | | | |
| 非流动负债合计 | 450,731,063.56 | 453,585,097.47 | 458,965,721.95 | 446,198,258.42 |
| 负债合计 | 1,121,203,958.43 | 1,079,448,183.49 | 1,101,748,981.57 | 1,169,501,554.59 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 828,256,153.13 | 816,827,275.35 | 822,925,147.9 | 821,363,596.57 |
| 股东权益合计 | 850,794,799.43 | 840,947,886.16 | 838,253,945.87 | 836,297,921.67 |
| 负债和股东权益合计 | 1,971,998,757.86 | 1,920,396,069.65 | 1,940,002,927.44 | 2,005,799,476.26 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 552,474,859.77 | 262,372,810.2 | 1,161,392,264.29 | 905,182,486.71 |
| 经营活动现金流出小计 | 566,587,674.56 | 271,246,175.11 | 1,087,341,982.11 | 873,085,591.55 |
| 经营活动产生的现金流量净额 | -14,112,814.79 | -8,873,364.91 | 74,050,282.18 | 32,096,895.16 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 109,389,389.3 | 51,355,552.2 | 160,744,773.16 | 42,788,896.31 |
| 投资活动现金流出小计 | 115,277,203.2 | 66,109,486.91 | 170,428,078.43 | 69,100,657.85 |
| 投资活动产生的现金流量净额 | -5,887,813.9 | -14,753,934.71 | -9,683,305.27 | -26,311,761.54 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 507,290,000 | 77,750,000 | 386,237,902.8 | 359,142,227.13 |
| 筹资活动现金流出小计 | 451,692,962.34 | 66,659,980.92 | 412,799,814.87 | 320,459,960 |
| 筹资活动产生的现金流量净额 | 55,597,037.66 | 11,090,019.08 | -26,561,912.07 | 38,682,267.13 |
| 汇率变动对现金及现金等价物的影响 | -3.28 | -2.13 | -5,759.7 | 5.57 |
| 现金及现金等价物净增加额 | 35,596,405.69 | -12,537,282.67 | 37,799,305.14 | 44,467,406.32 |
| 期末现金及现金等价物余额 | 219,041,332.26 | 170,907,643.9 | 183,444,926.57 | 190,113,027.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 35,596,405.69 | - | 37,799,305.14 | - |